BrandWikiReturn

Xellia

Xellia ApS is a Danish multinational pharmaceutical and life sciences company headquartered in Copenhagen[1] specialized in the production of anti-biotics, including Vancomycin[2] and Bacitracin.[3]

The company's US base of operations is in Buffalo Grove, Illinois,[4][5] with additional facilities in Ohio, and North Carolina.[6][7] In 2018, Xellia's sales in the United States accounted for 60% of its total revenue.[5]

Products

The company's main output is bulk drug chemicals which are wholesaled to other companies for packaging and distribution. Recently some prepackaged goods have been produced.

Active drug substances manufactured are:[8]

Discontinued products

Previously the company also produced:

Partnerships

In 2019, Xellia partnered with Civica Rx to produce generic Vancomycin and Daptomycin. The partnership's stated aim is to remedy chronic drug shortages that have affected the American pharmaceutical market.[4][10][11][12][13]

China-US Trade War

Xellia has been discussed as a potential alternative to Chinese companies for anti-biotic primary ingredients in the context of the China-United States trade war.[14]

See also

References

  1. Xellia Pharmaceuticals ApS Bloomberg, 2019-05-15, retrieved 15 July 2019^
  2. VANCOMYCIN HYDROCHLORIDE U.S. National Library of Medicine, 2019-05-15, retrieved 10 September 2019^
  3. BACITRACIN- bacitracin injection U.S. National Library of Medicine, retrieved 10 September 2019^
  4. Xellia to produce Civica antibiotics Chicago Daily Herald, 2019-05-15, retrieved 15 July 2019^
  5. Danish pharmaceutical company picks Chicago area for new office Chicago Business Journal, retrieved 15 July 2019^
  6. Will China Save the American Economy? The Atlantic, 2017-06-27, retrieved 15 July 2019^
  7. Denmark-based pharmaceuticals company acquires Raleigh manufacturing plant Triangle Business Journal, retrieved 21 July 2019^
  8. produktet listen er hentet fra Api på xellia.com 15. august 2014 og supplert med informasjon fra Vår arv hentes samme dag^
  9. Legemiddelsøk retrieved 4 September 2016^
  10. Two crucial antibiotics are the first products of Utah's new nonprofit drug company Salt Lake Tribune, retrieved 15 July 2019^
  11. Drugmaker Created To Reduce Shortages And Prices Unveils Its First Products NPR, retrieved 15 July 2019^
  12. Melanie Evans. Hospital Drug-Making Venture Picks Antibiotics as First Products Wall Street Journal, 15 May 2019, retrieved 15 July 2019^
  13. Jenny Deam. Unique initiative to lower drug prices signs manufacturer Houston Chronicle, 20 May 2019, retrieved 22 July 2019^
  14. Trade War With China Threatens To Make Problems With Generic Medicine Worse Forbes, retrieved 15 July 2019^
  15. <ref name=legemiddelverket_status> Godkjent eller ikke godkjent – hvilke statuser kan et legemiddel ha? retrieved 27 August 2016^
  16. Legemiddelsøk retrieved 27 August 2016^
  17. Legemiddelsøk retrieved 27 August 2016^
  18. Legemiddelsøk retrieved 27 August 2016^
  19. Legemiddelsøk retrieved 27 August 2016^
  20. Legemiddelsøk retrieved 27 August 2016^
  21. Legemiddelsøk retrieved 27 August 2016^
  22. Legemiddelsøk retrieved 27 August 2016^
  23. Legemiddelsøk retrieved 27 August 2016^
  24. Dumex. A/S DUMEX 2 February 1968^
  25. Asker og bærums budstikke. Nytt kontor- og lagerbygg på Haslum 26 February 1968^
  26. Fra Lysaker til Heggedal, 50 år 6 January 1976^
  27. På den annen side, Bærumsmann ny direktør for A/S Dumex, Høvik 6 March 1981^
  28. Inn i nybygg på Hvalstad 4 October 1982^
  29. Nekrolog: Torvall Westly 17 July 2015^